Product Details:
| Strength | 30mg/ml |
| Brand | Fasenra |
| Pack Size | 1 Prefilled Syringe |
| Originator | AstraZeneca |
| Patient Type | Adult |
| Prescription | Prescription |
| Storage | 2-8 Deg C |
| Form | Injection |
| Route | Subcutaneous |
| Shelf Life | 24 Month |
Product Details:
| Strength | 8ml Vial |
| Pack Size | 1 Vial |
| Brand | Survanta |
| Patient Type | Neonate |
| Usage | RDS, Preterm Infant |
| Origin | Bovine |
| Storage | 2-8 Deg C |
| Route | Intratracheal |
SURVANTA INJECTION 8ML belongs to a class of drugs called pulmonary surfactants. It is used in the treatment/prevention of premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient lung surfactant.
SURVANTA INJECTION 8ML contains Beractant, a natural surfactant that acts similarly to the baby's own surfactant, helping your baby to breathe normally. It will help your baby breathe normally until it produces its own surfactant.
SURVANTA INJECTION 8ML will be given to your baby in a hospital by a suitably trained doctor. Sometimes, SURVANTA INJECTION 8ML may cause a slow heart rate, endotracheal tube blockage, and low blood oxygen levels. Talk to the doctor if you have any concerns.
Product Details:
| Dose | 5 ml |